Financial Data and Key Metrics Changes - Third quarter revenues reached $58.4 million, representing a 21% year-over-year increase [7][18] - Adjusted EBITDA increased by 27% year-over-year to $6.4 million, with an adjusted EBITDA margin improvement of 50 basis points to 11% [10][23] - Gross margin improved to 81%, up from 78.9% in the prior year [21] - Adjusted non-GAAP net income was $3.5 million, or $0.26 per fully diluted share, compared to $2.8 million, or $0.21 per fully diluted share in the prior year [22] Business Line Data and Key Metrics Changes - The MINDBODY GLP-one system was the primary growth driver, with U.S. revenues growing by 31% year-over-year [8] - Active accounts in the Americas increased by 17% year-over-year, with a 13% increase in independent consultants and a 19% increase in customers [11] - Subscription orders showed positive trends, with 85% of new customers opting for subscriptions during the quarter [30] Market Data and Key Metrics Changes - Revenue in the Americas increased by 29.5% to $48.2 million, while revenue in Asia Pacific and Europe decreased by 7.2% to $10.2 million [19][20] - Japan's revenue increased by 2.7% on a constant currency basis, reflecting the launch of the MINDBODY system [20] Company Strategy and Development Direction - The company is focused on enhancing digital capabilities, building brand awareness, and maintaining strong profitability metrics while funding growth initiatives [15] - The EVOLVE compensation plan aims to provide consultants with multiple income streams and support their business growth [13] - The company plans to complete the global rollout of the MINDBODY system in remaining markets later this year [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the MINDBODY system's potential for long-term transformational impact on the business [16] - The company anticipates fiscal year 2025 revenue to be between $228 million and $235 million, representing a 16% increase year-over-year at the midpoint [25] - Management acknowledged challenges in international markets but remains optimistic about future growth opportunities [38] Other Important Information - The company held its annual global convention, revealing positive results from a clinical study on the MINDBODY system, which showed an average increase of GLP-one levels by over 200% [14][15] - A quarterly cash dividend of $0.45 per share was announced, totaling approximately $600,000 [25] Q&A Session Summary Question: What percentage of new customers are coming in on subscription? - Management noted a slight decline in active accounts sequentially, but subscription rates increased, with 85% of new customers on subscriptions during the quarter [30] Question: Are there more purchases in stacks versus standalone products? - Management confirmed that about 55% of revenue during the quarter was from standalone MINDBODY products, while 45% were from stacked purchases with other products [32] Question: What is the reason for the revenue outlook change? - Management indicated that the revenue reduction is due to both past results and anticipated results, with challenges from the initial product launch now resolved [36][38] Question: What have been the learnings about the MINDBODY product? - Management highlighted the importance of educating the sales force on the product's long-term health benefits rather than positioning it solely for weight loss [44][48]

Company Overview - UMeWorld Limited is focused on redefining the cooking oil industry through science and innovation, with its flagship product, DAGola, containing up to 50% less triglycerides than traditional oils [6] - DAGola is clinically proven in multiple human trials to support heart health and improve lipid metabolism, targeting metabolic syndrome which affects over 47 million Americans [6] - The company utilizes proprietary enzymatic technology to produce functional oils and eco-friendly biofuels from palm and used cooking oils [6] Clinical Study Results - A clinical study involving 820 adult participants demonstrated that regular consumption of diacylglycerol (DAG) oil led to significant improvements in health markers such as uric acid, triglycerides, cholesterol, and body weight [1][2] - After one month of DAG oil consumption, participants showed significant reductions in uric acid (P < 0.01), total cholesterol (P < 0.01), and LDL-C (P < 0.05) [3] - After two months, weight and BMI dropped significantly (P < 0.01), uric acid remained significantly reduced (P < 0.01), and triglyceride levels decreased markedly (P < 0.001) [3] Product Positioning - DAGola is positioned not only as a premium culinary oil but also as a functional nutrition solution backed by clinical evidence, offering a practical way to help individuals manage their health [3][4] - The product line includes four high-performance DAG-based oils: Gourmet Blend, Vitality Blend, Master Chef Blend, and Premium Blend, each designed for culinary excellence and metabolic support [5] - DAGola products are specially formulated to provide a significantly higher DAG content compared to conventional oils, enhancing wellness benefits [5] Market Context - Metabolic diseases, including type 2 diabetes, obesity, and cardiovascular disease, affect hundreds of millions globally and are largely preventable through dietary and lifestyle changes [4] - Functional foods like DAGola offer a practical solution for individuals to take control of their health from their kitchens [4]